The European Journal of Health Economics

2002 - 2025

Current editor(s): J.-M.G.v.d. Schulenburg

From:
Springer
Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)
Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 11, issue 6, 2010

A French approach to cost-effectiveness analysis? pp. 521-523

Gérard Pouvourville

The direct, indirect and intangible costs of visual impairment caused by neovascular age-related macular degeneration pp. 525-531

Kathleen Ke

Adolescents alcohol-use and economic conditions: a multilevel analysis of data from a period with big economic changes pp. 533-541

Mikael Svensson and Curt Hagquist

The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands pp. 543-554

Marcus Keogh-Brown, Richard Smith, John Edmunds and Philippe Beutels

The effect of health care expenditure on sickness absence pp. 555-568

David Granlund

The sustainability of public health expenditures: evidence from the Canadian federation pp. 569-584

Livio Di Matteo

The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden pp. 585-594

Michael Willis, Marianne Svensson, Mickael Löthgren, Bo Eriksson, Anders Berntsson and Ulf Persson

On the welfare theoretic foundation of CEA: comment pp. 595-596

Friedrich Breyer

Cost-effectiveness analysis, welfare economics, and the societal perspective: a reply pp. 597-598

Bengt Liljas

Erratum to: Hospital’s activity-based financing system and manager–physician interaction pp. 599-599

David Crainich, Hervé Leleu and Ana Mauleon

Volume 11, issue 5, 2010

EJHE has an official impact factor of 1.337 pp. 435-435

Johann Graf von der Schulenburg

Health insurance for the poor: impact on catastrophic and out-of-pocket health expenditures in Mexico pp. 437-447

Omar Galarraga, Sandra Sosa-Rubí, Aarón Salinas-Rodríguez and Sergio Sesma-Vázquez

Expenditures of the German statutory health insurance system for patients suffering from acute coronary syndrome and treated with percutaneous coronary intervention pp. 449-455

Heiko Friedel, Anne Delges, Johannes Clouth and Dana Trautvetter

Health impairments and labour market outcomes pp. 457-469

Nick Drydakis

Onset of disability and life satisfaction: evidence from the German Socio-Economic Panel pp. 471-485

Ricardo Pagán-Rodríguez

Health care utilisation and immigration in Spain pp. 487-498

José Ignacio Antón and Rafael Muñoz de Bustillo

Use of formal and informal care services among older people in Ireland and France pp. 499-511

Brenda Gannon and Bérengère Davin-Casalena

Spanish recommendations on economic evaluation of health technologies pp. 513-520

Julio López-Bastida, Juan Oliva, Fernando Antoñanzas, Anna García-Altés, Ramón Gisbert, Javier Mar and Jaume Puig-Junoy

Volume 11, issue 4, 2010

Feeding the economics of obesity in the EU in a healthy way pp. 351-353

Fernando Antonanzas and Roberto Rodríguez

Optimal savings and health spending over the life cycle pp. 355-365

Tamara Fioroni

The challenge of corporatisation: the experience of Portuguese public hospitals pp. 367-381

Guilhermina Rego, Rui Nunes and José Costa

Geographic distribution of physicians in Portugal pp. 383-393

Isabel Correia and Paula Veiga

Geographic distribution of physicians in Portugal pp. 383-393

Isabel Correia and Paula Veiga

Substituting inpatient for outpatient care: what is the impact on hospital costs and efficiency? pp. 395-404

Kirsi Vitikainen, Miika Linna and Andrew Street

Determinants of health care costs of HIV-positive patients in the Canary Islands, Spain pp. 405-412

Juan Oliva, Julio López-Bastida, Pedro Serrano-Aguilar and Lilisbeth Perestelo-Pérez

Adverse selection in the health insurance market: some empirical evidence pp. 413-418

Marcelo Resende and Rodrigo Zeidan

Modeling stroke management: a qualitative review of cost-effectiveness analyses pp. 419-426

Chantal Guilhaume, Delphine Saragoussi, John Cochran, Clément François and Mondher Toumi

Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences pp. 427-434

Ralph Crott and Andrew Briggs

Volume 11, issue 3, 2010

Future challenges for health economics and health technology assessment of biological drugs pp. 235-238

László Gulácsi

BMI and Spanish labour status: evidence by gender from the city of Barcelona pp. 239-253

Toni Mora

The impact of missing data in the estimation of concentration index: a potential source of bias pp. 255-266

Hai Zhong

The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany pp. 267-277

Tom Stargardt

Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: hospital-level prescription of thiazolidinediones for diabetes pp. 279-290

Yi-Wen Tsai, Yu-Wen Wen, Weng-Foung Huang, Ken Kuo, Pei-Fen Chen, Hsin-Wei Shih and Yue-Chune Lee

Principal agent relationships and the efficiency of hospitals pp. 291-304

Martijn Ludwig, Frits Merode and Wim Groot

The welfare costs of HIV/AIDS in Eastern Europe: an empirical assessment using the economic value-of-life approach pp. 305-322

Julia Fimpel and Michael Stolpe

Eliciting health state utilities from the general public for severe chronic pain pp. 323-330

S. Eldabe, A. Lloyd, L. Verdian, M. Meguro, G. Maclaine and S. Dewilde

Copayments for ambulatory care in Germany: a natural experiment using a difference-in-difference approach pp. 331-341

Jonas Schreyögg and Markus Grabka

The Irish ‘health basket’: a basket case? pp. 343-350

Samantha Smith

Volume 11, issue 2, 2010

US health care reform: a work in progress pp. 117-118

Sean Sullivan

Inpatient length of stay: a finite mixture modeling analysis pp. 119-126

Chungkham Singh and Laishram Ladusingh

In which ways do unhealthy people older than 50 exit the labour market in France? pp. 127-140

Thomas Barnay

The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population pp. 141-150

Dieter Tscheulin and Florian Drevs

Interactions between cigarette and alcohol consumption in rural China pp. 151-160

Xiaohua Yu and David Abler

Primary care delivery, risk pooling and economic efficiency pp. 161-175

Michael Leung

Saving lives, money and resources: drug and CABG/PCI use after myocardial infarction in a Swedish record-linkage study pp. 177-184

Lars Wilhelmsen, Lennart Welin, Anders Odén and Arne Björnberg

Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study pp. 185-193

Greg Lissovoy, Kathy Fraeman, John Teerlink, John Mullahy, Jeff Salon, Raimund Sterz, Amy Durtschi and Robert Padley

A case study of ex ante, value-based price and reimbursement decision-making: TLV and rimonabant in Sweden pp. 195-203

Ulf Persson, Michael Willis and Knut Ödegaard

A social preference valuations set for EQ-5D health states in Flanders, Belgium pp. 205-213

Irina Cleemput

A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures pp. 215-225

John Brazier, Yaling Yang, Aki Tsuchiya and Donna Rowen

Health insurance in Croatia: dynamics and politics of balancing revenues and expenditures pp. 227-233

Luka Voncina, Jenni Kehler, Tamas Evetovits and Mario Bagat

Volume 11, issue 1, 2010

HTA in Germany: very special and specific pp. 1-3

Wolfgang Greiner and J.-Matthias Schulenburg

On the welfare theoretic foundation of cost-effectiveness analysis—the case when survival is not affected pp. 5-13

Bengt Liljas

Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany: a model approach pp. 15-25

Jan Jürgensen, Wolfgang Arns and Bastian Haß

Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational study pp. 27-34

Feng Xie, Ngai-Nung Lo, Jean-Eric Tarride, Daria O’Reilly, Ron Goeree and Hin-Peng Lee

Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective pp. 35-44

Montserrat Vera-Llonch, Ellen Dukes, Javier Rejas, Oleg Sofrygin, Marko Mychaskiw and Gerry Oster

The added value of thorough economic evaluation of telemedicine networks pp. 45-55

Myriam Le Goff-Pronost and Claude Sicotte

An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? pp. 57-66

Rachel Elliott, Helen Weatherly, Neil Hawkins, Gillian Cranny, Duncan Chambers, Lindsey Myers, Alison Eastwood and Mark Sculpher

Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis pp. 67-76

Yogesh Punekar and Neil Hawkins

Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings pp. 77-94

Harald Hamre, Claudia Witt, Anja Glockmann, Renatus Ziegler, Gunver Kienle, Stefan Willich and Helmut Kiene

Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure pp. 95-104

Sonja Merkesdal, Timm Kirchhoff, Diane Wolka, Gunter Ladinek, Adrian Kielhorn and Andrea Rubbert-Roth

Cost effectiveness of palivizumab in Spain: an analysis using observational data pp. 105-115

Mark Nuijten and Wolfgang Wittenberg